TA
Thameem Ansari
About Thameem Ansari
Data last updated:
Thameem Ansari is an Additional Director at Grant Impeco Private Limited (since 2024) and Director at Skytrust Pharmaceutical Private Limited (since 2025). The largest current company by reported revenue is Grant Impeco Private Limited at ₹2.34 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Grant Impeco Private Limited U47721DL2023PTC411662 | Additional Director | 11 Jan 2024 | 2023 | ₹2.34 Cr (FY 2025) | Active |
| Skytrust Pharmaceutical Private Limited U47721DL2025PTC458236 | Director | 20 Nov 2025 | 2025 | Active |
Board colleagues of Thameem Ansari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sathish | 10090168 | Grant Impeco Private Limited , Skytrust Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Thameem Ansari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thameem Ansari
Thameem Ansari currently holds 2 directorships: Grant Impeco Private Limited (Additional Director, since 11 Jan 2024, revenue ₹2.34 Cr (FY 2025)); Skytrust Pharmaceutical Private Limited (Director, since 20 Nov 2025).
Thameem Ansari was first appointed on 11 Jan 2024 as Additional Director at Grant Impeco Private Limited. The most recent appointment on record is 20 Nov 2025 at Skytrust Pharmaceutical Private Limited.
The current boards of Thameem Ansari's companies include Sathish (Grant Impeco Private Limited).